Finally, elevated levels of Aβ42, p-tau, and matrix metallopeptidase 9 (MMP-9) were observed in L1CAM+ EVs of AD patients compared to healthy controls, proposing MMP-9 as a promising inflammatory biomarker [103]. Here, MMP9 is linked to Alzheimer disease.